Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Novartis Pharmaceuticals UK Ltd
Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 24/02/2012
PIL SANDIMMUN Concentrate for Solution for infusion 50mg/ml

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to information about pregnancy or lactation
Updated on 09/08/2011 and displayed until 24/02/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 14/12/2010 and displayed until 09/08/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 03/12/2009 and displayed until 14/12/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 11/09/2008 and displayed until 03/12/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
Updated on 18/04/2008 and displayed until 11/09/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 01/02/2008 and displayed until 18/04/2008
Reasons for adding or updating:
  • Change of contra-indications
  • Change due to user-testing of patient information
Updated on 27/01/2005 and displayed until 01/02/2008
Reasons for adding or updating:
  • Change of trade or generic name
Updated on 26/08/2004 and displayed until 27/01/2005
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
Updated on 12/02/2003 and displayed until 26/08/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 02/01/2001 and displayed until 12/02/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  ciclosporin